Journal of Drugs in Dermatology

SJR Rank #9,438H-index: 79SJR: 0.623Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Journal of Drugs in Dermatology

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • DermatologyQ2
  • Medicine (miscellaneous)Q2

Areas: Medicine

Most published research topics

Dermatologic Treatments and ResearchAcne and Rosacea Treatments and EffectsDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisSkin Protection and AgingNonmelanoma Skin Cancer StudiesHair Growth and DisordersAutoimmune Bullous Skin DiseasesCutaneous Melanoma Detection and ManagementFacial Rejuvenation and Surgery Techniques

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025065130195260

Detailed Information

ISSN

1545-9616

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

1.72

References per Document

19.11

Coverage

2002-2026

Scope

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.

Metrics from SCImago Journal Rank 2025. View on SCImago